Literature DB >> 20517807

Lymphocytic colitis under treatment with duloxetine.

B Kusnik1, M Stolte.   

Abstract

Lymphocytic colitis is a disease characterised by chronic watery diarrhoea that can only be diagnosed histologically, since colonoscopy reveals macroscopically normal mucosa. A causal relationship to the administration of certain drugs has repeatedly been described. In this report we describe a case of lymphocytic colitis that developed after initiation of treatment with duloxetine - a selective serotonin- and noradrenaline-reuptake inhibitor - and remitted after discontinuation of the drug. Since a causal relationship between the onset of lymphocytic colitis and the use of duloxetine is highly probable, duloxetine should be included among those drugs capable of inducing lymphocytic colitis. Georg Thieme Verlag KG Stuttgart. New York.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20517807     DOI: 10.1055/s-0028-1109814

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  4 in total

1.  Mixed lymphocytic and collagenous inflammation of the entire gastrointestinal tract under therapy with serotonin and norepinephrine reuptake inhibitors.

Authors:  Ana I Varelas; Stefan Fürst; Cord Langner
Journal:  Virchows Arch       Date:  2022-06-02       Impact factor: 4.064

2.  Cherry-tree colon: colonoscopic appearance suggesting drug-induced mucosal injury.

Authors:  Maria Pina Dore; Vincenzo Villanacci; Alessandra Manca; Sara Soro; Marco Schiavo-Lena; Giuseppe Sabatino; David Yates Graham; Gabrio Bassotti
Journal:  Intern Emerg Med       Date:  2013-03-15       Impact factor: 3.397

Review 3.  Drug Exposure and the Risk of Microscopic Colitis: A Critical Update.

Authors:  Alfredo J Lucendo
Journal:  Drugs R D       Date:  2017-03

4.  European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations.

Authors:  Stephan Miehlke; Danila Guagnozzi; Yamile Zabana; Gian E Tontini; Anne-Marie Kanstrup Fiehn; Signe Wildt; Johan Bohr; Ole Bonderup; Gerd Bouma; Mauro D'Amato; Peter J Heiberg Engel; Fernando Fernandez-Banares; Gilles Macaigne; Henrik Hjortswang; Elisabeth Hultgren-Hörnquist; Anastasios Koulaouzidis; Jouzas Kupcinskas; Stefania Landolfi; Giovanni Latella; Alfredo Lucendo; Ivan Lyutakov; Ahmed Madisch; Fernando Magro; Wojciech Marlicz; Emese Mihaly; Lars K Munck; Ann-Elisabeth Ostvik; Árpád V Patai; Plamen Penchev; Karolina Skonieczna-Żydecka; Bas Verhaegh; Andreas Münch
Journal:  United European Gastroenterol J       Date:  2021-02-22       Impact factor: 4.623

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.